An initiative by

Friends of the Global Fund, Japan (FGFJ), is dedicated to strengthening support in Japan for the Global Fund to Fight AIDS, Tuberculosis and Malaria.

The Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund) is credited with saving countless lives from the three deadliest communicable diseases—HIV/AIDS, tuberculosis, and malaria.

TB screening that once took hours now happens in seconds.

AI can quickly scan for signs of TB, speeding up detection, diagnosis & access to lifesaving treatment, even in hard-to-reach areas.

Read how innovation is saving lives in Mali & beyond: https://stories.theglobalfund.org/fa4202b7a069adc297dad1abc7e7fa83#section-6863339

On the frontlines of the war in Ukraine, nurse Natalya uses a GeneXpert machine to diagnose TB – and detect drug resistance – in under two hours.

Since 2020, the @GlobalFund has provided more than 200 GeneXpert machines to Ukraine & has expanded access to this lifesaving tool

Investing in the fight against TB reinforces global health security by strengthening disease surveillance systems and laboratory networks – which are key to protecting against future health threats and antimicrobial resistance. #WorldTBDay

https://www.theglobalfund.org/en/events/world-tuberculosis-day/

TB caused over 1.2 million deaths in 2024, remaining the world’s deadliest infectious disease. 🫁 The @GlobalFund is working hand in hand with governments, civil society, communities & the private sector to scale innovations & reach the people who need them most.
#WorldTBDay

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

「まさか、自分が……」
ReHacQプロデューサー・高橋さんのこの言葉は、決して他人事ではありません。

日本でも約1万人(2024年)が発症している「結核」。かつての病気だと思われがちですが、実は誰でもかかる可能性のある、今もそばにある感染症です。

結核は適切な治療で完治できる病気です。しかし、私たちの「無関心」や「古い偏見」が、早期発見を遅らせ、克服への大きな壁となっています。

正しく知り、偏見という壁をなくすこと。
それが、いまだに世界中で多くの命を奪う「結核」をなくすための第一歩になります。

多様な視点から5人が「結核」を語る動画↓ ぜひ、ご覧ください
🎥 youtube.com/watch?v=6LaiFcIf-Tw
#EndTB #結核を終わらせよう #グローバルファンド The Global Fund
... See MoreSee Less

2 days ago
Iframe Video Thmbnail

0 CommentsComment on Facebook